412
Views
5
CrossRef citations to date
0
Altmetric
Invited Review Articles

Essential role of laboratory physicians in transformation of laboratory practice and management to a value-based patient-centric model

&
Pages 323-344 | Received 03 Sep 2019, Accepted 21 Jan 2020, Published online: 17 Mar 2020

References

  • Wright JR Jr. The politics underlying the provision of and changes in pathology and laboratory services in the United States during the roaring twenties. Arch Pathol Lab Med. 2016;140:983–991.
  • Plebani M. Quality and future of clinical laboratories: the Vico’s whole cyclical theory of the recurring cycles. Clin Chem Lab Med. 2018;56:901–908.
  • Plebani M, Laposata M, Lundberg GD. The brain-to-brain loop concept for laboratory testing 40 years after its introduction. Am J Clin Pathol. 2011;136:829–833.
  • Price CP. Roots, development and future directions of laboratory medicine. Clin Chem Lab Med. 2010;48:903–909.
  • Pantanowitz L, Henricks WH, Beckwith BA. Medical laboratory informatics. Clin Lab Med. 2007;27:823–843.
  • Kudler NR, Pantanowitz L. Overview of laboratory data tools available in a single electronic medical record. J Pathol Inform. 2010;1:2153.
  • Mongan J, Avrin D. Impact of PACS-EMR integration on radiologist usage of the EMR. J Digit Imag. 2018;31:611–614.
  • Drain PK, Hyle EP, Noubary F, et al. Diagnostic point-of-care tests in resource-limited settings. Lancet Infect Dis. 2014;14:239–249.
  • Kumar AA, Hennek JW, Smith BS, et al. From the bench to the field in low-cost diagnostics: two case studies. Angew Chem Int Ed Engl. 2015;54:5836–5853.
  • Wright JR Jr. Calgary laboratory services: a unique Canadian model for an academic Department of Pathology and Laboratory Medicine succeeding in the face of provincial integration of public, private, and academic laboratories. Acad Pathol. 2015;2:237428951561994.
  • Church DL, Naugler C. Benefits and risks of standardization, harmonization and conformity to opinion in clinical laboratories. Crit Rev Clin Lab Sci. 2019;56:287–306.
  • Conn RB. Clinical laboratories. Profit center, production industry or patient-care resource? N Engl J Med. 1978;298:422–427.
  • Price CP, John AS, Christenson R, et al. Leveraging the real value of laboratory medicine with the value proposition. Clin Chim Acta. 2016;462:183–186.
  • Gray S, Voutyras J, Hannan D, et al. Improved laboratory efficiency through cooperation, consultation, and consolidation. Am Clin Lab. 2002;21:28–31.
  • Price CP, St John A. Innovation in healthcare. The challenge for laboratory medicine. Clin Chim Acta. 2014;427:71–78.
  • Plebani M, Laposata M, Lippi G. A manifesto for the future of laboratory medicine professionals. Clin Chim Acta. 2019;489:49–52.
  • Crossey M. 2019. Keynote Presentation: Clinical Laboratory 2.0 - How laboratories can thrive in a value based care system. LabRoots Molecular Diagnostics Virtual Event 2019. Available from: https://www.youtube.com/watch?v=e8RP6EGmJOM
  • Dorrance KA, Robbins DA, Kimsey L, et al. Toward a national conversation on health: disruptive intervention and the transformation from health care to health. Mil Med. 2018;183:193–197.
  • Naugler C, Church DL. Automation and artificial intelligence in the clinical laboratory. Crit Rev Clin Lab Sci. 2019;56:98–110.
  • Applebaum B, Robbins S. Language access and health equity: changes under the Affordable Care Act. J Health Care Poor Underserved. 2016;27:416–426.
  • Horrill T, McMillan DE, Schultz ASH, et al. Understanding access to healthcare among indigenous peoples: a comparative analysis of biomedical and postcolonial perspectives. Nurs Inq. 2018;25:e12237.
  • Florkowski C, Don-Wauchope A, Gimenez N, et al. Point-of-care testing (POCT) and evidence-based laboratory medicine (EBLM) - does it leverage any advantage in clinical decision making?. Crit Rev Clin Lab Sci. 2017;54:471–494.
  • Drancourt M, Michel-Lepage A, Boyer S, et al. The point-of-care laboratory in clinical microbiology. Clin Microbiol Rev. 2016;29:429–447.
  • Morel C, McClure L, Edwards S, et al. editors. Ensuring innovation in diagnostics for bacterial infection: implications for policy [Internet]. Copenhagen (Denmark): European Observatory on Health Systems and Policies; 2016. (Observatory Studies Series, No. 44.) Available from: http://www.euro.who.int/__data/assets/pdf_file/0008/302489/Ensuring-innovation-diagnostics-bacterial-infection-en.pdf?ua=1
  • Riley GF, Lubitz JD. Long-term trends in Medicare payment in the last year of life. Health Serv Res. 2010;45:557–565.
  • ASC Communications. 2013. The future of hospitals: visions of the healthcare landscape in 2035. Becker’s Hospital Review. Available from: https://www.beckershospitalreview.com/hospital-management-administration/the-future-of-hospitals-visions-of-the-healthcare-landscape-in-2035.html
  • Hammett-Stabler CA, Nichols JH. Point-of-care testing, a critical component of laboratory medicine. Clin Biochem. 2009;42:135.
  • Price CP, St John A. 2019. The value proposition for point-of-care testing in healthcare: HbA1c for monitoring in diabetes management as an exemplar. Scand J Clin Lab Invest 79:298–304.
  • Nkengasong JN, Mbopi-Keou FX, Peeling RW, et al. Laboratory medicine in Africa since 2008: then, now, and the future. Lancet Infect Dis. 2018;18:e362–e367.
  • Ferraro S, Braga F, Panteghini M. Laboratory medicine in the new healthcare environment. Clin Chem Lab Med. 2016;54:523–533.
  • Ross F, Smith P, Byng R, et al. Learning from people with long-term conditions: new insights for governance in primary healthcare. Health Soc Care Commun. 2014;22:405–416.
  • Vance RP. Outcomes management. New opportunities in a shrinking pathology market. Arch Pathol Lab Med. 1997;121:1183–1186.
  • Elliott MJ, Gil S, Hemmelgarn BR, et al. A scoping review of adult chronic kidney disease clinical pathways for primary care. Nephrol Dial Transplant. 2017;32:838–846.
  • Ma I, Guo M, Muruve D, et al. Sociodemographic associations with abnormal estimated glomerular filtration rate (eGFR) in a large Canadian city: a cross-sectional observation study. BMC Nephrol. 2018;19:198.
  • Ko SQ, Quah P, Lahiri M. The cost of repetitive laboratory testing for chronic disease. Intern Med J. 2019;49:1168–1170.
  • Lippi G, Brambilla M, Bonelli P, et al. Effectiveness of a computerized alert system based on re-testing intervals for limiting the inappropriateness of laboratory test requests. Clin Biochem. 2015;48:1174–1176.
  • Thomas RE, Vaska M, Naugler C, et al. Interventions at the laboratory level to reduce laboratory test ordering by family physicians: systematic review. Clin Biochem. 2015;48:1358–1365.
  • Goldman LL, Rudd P. Ten commandments for effective consultation. Arch Intern Med. 1984;143:25–39.
  • Burke MD. Clinical laboratory consultation. Clin Chem. 1995;41:1237–1240.
  • Hickner J, Thompson PJ, Wilkinson T, et al. Primary care physicians’ challenges in ordering clinical laboratory tests and interpreting results. J Am Board Fam Med. 2014;27:268–274.
  • Rotter T, Kinsman L, James E, et al. Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs. Cochrane Database Syst Rev. 2010;CD006632.
  • Buchert AR, Butler GA. Clinical pathways: driving high-reliability and high-value care. Pediatr Clin North Am. 2016;63:317–328.
  • Chiang AC, Ellis P, Zon R. Perspectives on the use of clinical pathways in oncology care. Am Soc Clin Oncol Educ Book. 2017;37:155–159.
  • Donald M, McBrien K, Jackson W, et al. Development and implementation of an online clinical pathway for adult chronic kidney disease in primary care: a mixed methods study. BMC Med Inform Decis Mak. 2016;16:109.
  • Jabbour M, Curran J, Scott SD, et al. Best strategies to implement clinical pathways in an emergency department setting: study protocol for a cluster randomized controlled trial. Implement Sci. 2013;8:55.
  • Page AJ, Gani F, Crowley KT, Lee KH, et al. Patient outcomes and provider perceptions following implementation of a standardized perioperative care pathway for open liver resection. Br J Surg. 2016;103:564–571.
  • Graber ML, Rusz D, Jones ML, et al. The new diagnostic team. Diagnosis (Berl). 2017;4:225–238.
  • van Hoeve JC, Vernooij RWM, Lawal AK, et al. Effects of oncological care pathways in primary and secondary care on patient, professional, and health systems outcomes: protocol for a systematic review and meta-analysis. Syst Rev. 2018;7:49.
  • Bernstein LH, Scott FI. Jr. Strategic considerations in clinical laboratory management: a laboratory leadership role in clinical pathways. Establishing the laboratory’s direct contribution to the institution’s performance. Clin Lab Manage Rev. 1997;11:116–124.
  • Laposata M. Errors in clinical laboratory test selection and result interpretation: commonly unrecognized mistakes as a cause of poor patient outcome. Diagnosis. 2014;1:85–87.
  • Laposata M, Dighe A. “Pre-pre” and “post-post” analytical error: high-incidence patient safety hazards involving the clinical laboratory. Clin Chem Lab Med. 2007;45:712–719.
  • Lundberg J, Nettleman MD, Costigan M, et al. Staphylococcus aureus bacteremia: the cost-effectiveness of long-term therapy associated with infectious diseases consultation. Clin Perform Qual Health Care. 1998;6:9–11.
  • Jenkins TC, Price CS, Sabel AL, et al. Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia. Clin Infect Dis. 2008;46:1000–1008.
  • Yamamoto S, Iwata K. Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia. Clin Infect Dis. 2008;47:432.
  • Lahey T, Shah R, Gittzus J, et al. Infectious diseases consultation lowers mortality from Staphylococcus aureus bacteremia. Medicine (Baltimore). 2009;88:263–267.
  • Honda H, Krauss MJ, Jones JC, et al. The value of infectious diseases consultation in Staphylococcus aureus bacteremia. Am J Med. 2010;123:631–637.
  • Fries BL, Licitra C, Crespo A, et al. Infectious diseases consultation and the management of Staphylococcus aureus bacteremia. Clin Infect Dis. 2014;58:598–599.
  • Turner RB, Valcarlos E, Won R, et al. Impact of infectious diseases consultation on clinical outcomes of patients with Staphylococcus aureus bacteremia in a community health system. Antimicrob Agents Chemother. 2016;60:5682–5687.
  • Buehrle K, Pisano J, Han Z, et al. Guideline compliance and clinical outcomes among patients with Staphylococcus aureus bacteremia with infectious diseases consultation in addition to antimicrobial stewardship-directed review. Am J Infect Control. 2017;45:713–716.
  • Bai AD, Showler A, Burry L, et al. Impact of infectious disease consultation on quality of care, mortality, and length of stay in Staphylococcus aureus bacteremia: results from a large multicenter cohort study. Clin Infect Dis. 2015;60:1451–1461.
  • Djelic L, Andany N, Craig J, et al. Automatic notification and infectious diseases consultation for patients with Staphylococcus aureus bacteremia. Diagn Microbiol Infect Dis. 2018;91:282–283.
  • Gandhi TK, Kachalia A, Thomas EJ, et al. Missed and delayed diagnoses in the ambulatory setting: a study of closed malpractice claims. Ann Intern Med. 2006;145:488–496.
  • Kachalia A, Gandhi TK, Puopolo AL, et al. Missed and delayed diagnoses in the emergency department: a study of closed malpractice claims from 4 liability insurers. Ann Emerg Med. 2007;49:196–205.
  • Studdert DM, Mello MM, Gawande AA, Gandhi TK, et al. Claims, errors, and compensation payments in medical malpractice litigation. N Engl J Med. 2006;354:2024–2033.
  • Plebani M. Towards a new paradigm in laboratory medicine: the five rights. Clin Chem Lab Med. 2016;54:1881–1891.
  • Verna R, Velazquez AB, Laposata M. Reducing diagnostic errors worldwide through diagnostic management teams. Ann Lab Med. 2019;39:121–124.
  • Dickerson JAA, Procop G, Keren DF, et al. Transforming laboratory utilization review into laboratory stewardship: guidelines by the PLUGS National Committee for Laboratory Stewardship. J Appl Lab Med. 2017;2:259–268.
  • Seegmiller AC, Kim AS, Mosse CA, et al. Optimizing personalized bone marrow testing using an evidence-based, interdisciplinary team approach. Am J Clin Pathol. 2013;140:643–650.
  • Patel R, Fang FC. Diagnostic stewardship: opportunity for a laboratory-infectious diseases partnership. Clin Infect Dis. 2018;67:799–801.
  • Madden GR, Weinstein RA, Sifri CD. diagnostic stewardship for healthcare-associated infections: opportunities and challenges to safely reduce test use. Infect Control Hosp Epidemiol. 2018;39:214–218.
  • Aquino AC. How to spot the savings from a diagnostic management team. CAP Today. 2017. Available from: http://captodayonline.com/spot-savings-diagnostic-team
  • Bookstaver PB, Nimmich EB, Smith TJ 3rd, et al. Cumulative effect of an antimicrobial stewardship and rapid diagnostic testing bundle on early streamlining of antimicrobial therapy in gram-negative bloodstream infections. Antimicrob Agents Chemother. 2017;61:e00189-17.
  • Sarkar MK, Botz CM, Laposata M. An assessment of overutilization and underutilization of laboratory tests by expert physicians in the evaluation of patients for bleeding and thrombotic disorders in clinical context and in real time. Diagnosis (Berl). 2017;4:21–26.
  • Healey R, Naugler C, de Koning L, et al. A classification tree approach for improving the utilization of flow cytometry testing of blood specimens for B-cell non-Hodgkin lymphoproliferative disorders. Leuk Lymphoma. 2015;56:2619–2624.
  • Papaioannou A, Kennedy CC, Campbell G, Stroud JB, Improving Prescribing in Long Term Care I, et al. A team-based approach to warfarin management in long term care: a feasibility study of the MEDeINR electronic decision support system. BMC Geriatr. 2010;10:38.
  • Araujo ALD, Arboleda LPA, Palmier NR, et al. The performance of digital microscopy for primary diagnosis in human pathology: a systematic review. Virchows Arch. 2019;474:269–287.
  • Garcia-Rojo M. International clinical guidelines for the Adoption of Digital Pathology: a review of technical aspects. Pathobiology. 2016;83:99–109.
  • Gru AA, Kim J, Pulitzer M, et al. The use of central pathology review with digital slide scanning in advanced-stage mycosis fungoides and Sezary syndrome: a multi-institutional and international pathology study. Am J Surg Pathol. 2018;42:726–734.
  • Liu Y, Pantanowitz L. Digital pathology: review of current opportunities and challenges for oral pathologists. J Oral Pathol Med. 2019;48:263–269.
  • van Diest PJ, Huisman A, van Ekris J, et al. Pathology image exchange: the Dutch digital pathology platform for exchange of whole-slide images for efficient teleconsultation, telerevision, and virtual expert panels. JCO Clin Cancer Inform. 2019;3:1–7.
  • Baidoshvili A, Stathonikos N, Freling G, et al. Validation of a whole-slide image-based teleconsultation network. Histopathology. 2018;73:777–783.
  • McLaughlin WJ, Schifman RB, Ryan KJ, et al. Telemicrobiology: feasibility study. Telemed J. 1998;4:11–17.
  • Rhoads DD, Mathison BA, Bishop HS, et al. Review of telemicrobiology. Arch Pathol Lab Med. 2016;140:362–370.
  • Rhoads DD, Sintchenko V, Rauch CA, et al. Clinical microbiology informatics. Clin Microbiol Rev. 2014;27:1025–1047.
  • Suhanic W, Crandall I, Pennefather P. An informatics model for guiding assembly of telemicrobiology workstations for malaria collaborative diagnostics using commodity products and open-source software. Malar J. 2009;8:164.
  • Rhoads DD, Habib-Bein NF, Hariri RS, et al. Comparison of the diagnostic utility of digital pathology systems for telemicrobiology. J Pathol Inform. 2016;7:10.
  • Booth AL, Katz MS, Misialek MJ, et al. Please help me see the dragon “I am slaying”: implementation of a novel patient-pathologist consultation program and survey of patient experience. Arch Pathol Lab Med. 2019;143:852–858.
  • Axilbund JE, Brune KA, Canto MI, et al. Patient perspective on the value of genetic counselling for familial pancreas cancer. Hered Cancer Clin Pract. 2005;3:115–122.
  • Axilbund JE, Hamby LA, Thompson DB, et al. Assessment of the use and feasibility of video to supplement the genetic counseling process: a cancer genetic counseling perspective. J Genet Counsel. 2005;14:235–243.
  • Sepulveda JL, Young DS. The ideal laboratory information system. Arch Pathol Lab Med. 2013;137:1129–1140.
  • Madden GR, Poulter MD, Sifri CD. Diagnostic stewardship and the 2017 update of the IDSA-SHEA Clinical Practice Guidelines for Clostridium difficile infection. Diagnosis (Berl). 2018;5:119–125.
  • Church D, Naugler C. Clinical laboratory utilization and improved healthcare performance. Crit Rev Clin Lab Sci. 2018;55:535–547.
  • Timbrook TT, Spivak ES, Hanson KE. Current and future opportunities for rapid diagnostics in antimicrobial stewardship. Med Clin North Am. 2018;102:899–911.
  • Rock C, Pana Z, Leekha S, CDC Prevention Epicenters Program, et al. National Healthcare Safety Network laboratory-identified Clostridium difficile event reporting: a need for diagnostic stewardship. Am J Infect Control. 2018;46:456–458.
  • Yen C, Holtom P, Butler-Wu SM, et al. Reducing Clostridium difficile colitis rates via cost-saving diagnostic stewardship. Infect Control Hosp Epidemiol. 2018;39:734–736.
  • Madden GR, Poulter MD, Sifri CD. PCR cycle threshold to assess a diagnostic stewardship intervention for C. difficile testing. J Infect. 2019;78:158–169.
  • Madden GR, Sifri CD. Reduced Clostridioides difficile Tests among solid organ transplant recipients through a diagnostic stewardship bundled intervention. Ann Transplant. 2019;24:304–311.
  • Wenzler E, Wong JR, Goff DA, et al. Controversies in antimicrobial stewardship: focus on new rapid diagnostic technologies and antimicrobials. Antibiotics (Basel). 2016;5.
  • Sullivan KV. Advances in diagnostic testing that impact infection prevention and antimicrobial stewardship programs. Curr Infect Dis Rep. 2019;21:20.
  • Marcelin JR, Brewer C, Beachy M, et al. Hardwiring diagnostic stewardship using electronic ordering restrictions for gastrointestinal pathogen testing. Infect Control Hosp Epidemiol. 2019;40:668–673.
  • Bolles K, Woc-Colburn L, Hamill RJ, et al. Ordering patterns and costs of specialized laboratory testing by hospitalists and house staff in hospitalized patients with HIV at a county hospital: an opportunity for diagnostic stewardship. Open Forum Infect Dis. 2019;6:ofz158.
  • Naugler C, Hemmelgarn B, Quan H, et al. Implementation of an intervention to reduce population-based screening for vitamin D deficiency: a cross-sectional study. CMAJ Open. 2017;5:E36–E39.
  • Romano RC, Allen TC, Blessing MM. The essential role of pathologists in health care and health policy. Arch Pathol Lab Med. 2015;139:441–444.
  • Plebani M, Laposata M, Lippi G. Driving the route of laboratory medicine: a manifesto for the future. Intern Emerg Med. 2019;14:337–340.
  • Kricka LJ, Polsky TG, Park JY, et al. The future of laboratory medicine - a 2014 perspective. Clin Chim Acta. 2015;438:284–303.
  • Weiss RL, McKenna BJ, Lord-Toof M, et al. A consensus curriculum for laboratory management training for pathology residents. Am J Clin Pathol. 2011;136:671–678.
  • CLSI. Quality management system: leadership and management roles and responsibilities; approved guideline. 1st ed. CLSI document QMS14. Wayne (PA): Clinical Laboratory Standards Institute; 2013.
  • Laposata M, Proytcheva MA, Rutledge JC, et al. Professional quality assurance in laboratory medicine: what about the competency of laboratory directors? Am J Clin Pathol. 2010;134:706–708.
  • Burke MD. Clinical laboratory consultation: appropriateness to laboratory medicine. Clin Chim Acta. 2003;333:125–129.
  • Garon JE. Principles of clinical laboratory utilization and consultation. Arch Pathol Lab Med. 2000;124:641–642.
  • Weinbren MJ, Collins M, Heathcote R, et al. Optimization of the blood culture pathway: a template for improved sepsis management and diagnostic antimicrobial stewardship. J Hosp Infect. 2018;98:232–235.
  • Giordano C, Piccoli E, Brucculeri V, et al. A prospective evaluation of two rapid phenotypical antimicrobial susceptibility technologies for the diagnostic stewardship of sepsis. Biomed Res Int. 2018;2018:6976923.
  • Mangioni D, Viaggi B, Giani T, et al. Diagnostic stewardship for sepsis: the need for risk stratification to triage patients for fast microbiology workflows. Future Microbiol. 2019;14:169–174.
  • Bouza E, Sousa D, Munoz P, et al. Bloodstream infections: a trial of the impact of different methods of reporting positive blood culture results. Clin Infect Dis. 2004;39:1161–1169.
  • Bunsow E, Gonzalez-Del Vecchio M, Sanchez C, et al. Improved sepsis alert with a telephone call from the clinical microbiology laboratory: a clinical trial. Medicine (Baltimore). 2015;94:e1454.
  • Patel S, Nanda R, Sahoo S, et al. Congruity in quality indicators and laboratory performance. Ind J Clin Biochem. 2018;33:341–347.
  • Ali SMH, Kathia UM, Gondal MUM, et al. Impact of clinical information on the turnaround time in surgical histopathology: a retrospective study. Cureus. 2018;10:e2596.
  • Vimalananda VG, Gupte G, Seraj SM, et al. Electronic consultations (e-consults) to improve access to specialty care: a systematic review and narrative synthesis. J Telemed Telecare. 2015;21:323–330.
  • Gupte G, Vimalananda V, Simon SR, et al. Disruptive innovation: implementation of electronic consultations in a veterans affairs health care system. JMIR Med Inform. 2016;4:e6.
  • Theparee T, Shanes E, Maurer D, et al. A new era in pathology consultation: the MyPathologist electronic consultation tool. Acad Pathol. 2018;5.
  • Allen LC. Role of a quality management system in improving patient safety - laboratory aspects. Clin Biochem. 2013;46:1187–1193.
  • CLSI. A quality management systems model for laboratory services; approved guideline. 5th ed. CLSI document QMS01. Wayne (PA): Clinical Laboratory Standards Institute; 2019.
  • CLSI. Quality management system: development and management of laboratory documents; approved guideline. 6th ed. CLSI document QMS02. Wayne (PA): Clinical Laboratory Standards Institute; 2018.
  • Ezzelle J, Rodriguez-Chavez IR, Darden JM, et al. Guidelines on good clinical laboratory practice: bridging operations between research and clinical research laboratories. J Pharm Biomed Anal. 2008;46:18–29.
  • Genzen JR, Mohlman JS, Lynch JL, et al. Laboratory-developed tests: a legislative and regulatory review. Clin Chem. 2017;63:1575–1584.
  • Katus HA, Remppis A, Neumann FJ, et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation. 1991;83:902–912.
  • Katus HA, Remppis A, Scheffold T, et al. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol. 1991;67:1360–1367.
  • Katus HA, Schoeppenthau M, Tanzeem A, et al. Non-invasive assessment of perioperative myocardial cell damage by circulating cardiac troponin T. Br Heart J. 1991;65:259–264.
  • Xu RY, Zhu XF, Yang Y, et al. High-sensitive cardiac troponin T. J Geriatr Cardiol. 2013;10:102–109.
  • Thygesen K, Mair J, Katus H, et al.; Study Group on Biomarkers in Cardiology of the ESCWGoACC. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J. 2010;31:2197–2204.
  • Melanson SE, Morrow DA, Jarolim P. Earlier detection of myocardial injury in a preliminary evaluation using a new troponin I assay with improved sensitivity. Am J Clin Pathol. 2007;128:282–286.
  • Cao JJ, Arnold AM, Manolio TA, et al. Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study. Circulation. 2007;116:32–38.
  • Cozlea DL, Farcas DM, Nagy A, et al. The impact of C reactive protein on global cardiovascular risk on patients with coronary artery disease. Curr Health Sci J. 2013;39:225–231.
  • Ridker PM, Kastelein JJ, Genest J, et al. C-reactive protein and cholesterol are equally strong predictors of cardiovascular risk and both are important for quality clinical care. Eur Heart J. 2013;34:1258–1261.
  • Black S, Kushner I, Samols D. C-reactive Protein. J Biol Chem. 2004;279:48487–48490.
  • Pliakos EE, Andreatos N, Shehadeh F, et al. The cost-effectiveness of rapid diagnostic testing for the diagnosis of bloodstream infections with or without antimicrobial stewardship. Clin Microbiol Rev. 2018;31.
  • Bouza E, Onori R, Semiglia-Chong MA, et al. Fast track SSTI management program based on a rapid molecular test (GeneXpert®MRSA/SA SSTI) and antimicrobial stewardship. J Microbiol Immunol Infect. 2018.
  • Hitchcock MM, Gomez CA, Banaei N. Low yield of FilmArray GI panel in hospitalized patients with diarrhea: an opportunity for diagnostic stewardship intervention. J Clin Microbiol. 2018;56.
  • Wolk DM, Clark AE. Matrix-assisted laser desorption time of flight mass spectrometry. Clin Lab Med. 2018;38:471–486.
  • Clark AE, Kaleta EJ, Arora A, et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry: a fundamental shift in the routine practice of clinical microbiology. Clin Microbiol Rev. 2013;26:547–603.
  • Hrabak J. Detection of carbapenemases using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) meropenem hydrolysis assay. Methods Mol Biol. 2015;1237:91–96.
  • Hrabak J, Chudackova E, Walkova R. Matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry for detection of antibiotic resistance mechanisms: from research to routine diagnosis. Clin Microbiol Rev. 2013;26:103–114.
  • Burd EM. Validation of laboratory-developed molecular assays for infectious diseases. Clin Microbiol Rev. 2010;23:550–576.
  • Caliendo AM, Gilbert DN, Ginocchio CC, et al. Infectious Diseases Society of America Better tests, better care: improved diagnostics for infectious diseases. Clin Infect Dis. 2013;57:S139–S70.
  • CLSI. Validation and verification of multiplex nucleic acid assays; approved guideline. 2nd ed. CLSI document MM17. Wayne (PA): Clinical Laboratory Standards Institute; 2018.
  • Riley SB. Trends in laboratory utilization. Clin Microbiol Newslett. 2017;39:69–73.
  • Naugler C. A perspective on laboratory utilization management from Canada. Clin Chim Acta. 2014;427:142–144.
  • Nguyen LT, Guo M, Hemmelgarn B, et al. Evaluating practice variance among family physicians to identify targets for laboratory utilization management. Clin Chim Acta. 2019;497:1–5.
  • Naugler C, Ma I. More than half of abnormal results from laboratory tests ordered by family physicians could be false-positive. Can Fam Phys. 2018;64:202–203.
  • Zhi M, Ding EL, Theisen-Toupal J, et al. The landscape of inappropriate laboratory testing: a 15-year meta-analysis. PLoS One. 2013;8:e78962.
  • Laposata M, Cohen MB. It’s our turn: implications for pathology from the Institute of Medicine’s Report on Diagnostic Error. Arch Pathol Lab Med. 2016;140:505–507.
  • Liu ZAA, Baskin L, Lewis G, et al. An intervention to reduce laboratory utilization of referred out tests. Lab Med. 2012;43:164–167.
  • Annen K, Peterson L, Reed K. Reducing laboratory costs through education-based gatekeeping. Arch Pathol Lab Med. 2014;138:301–301.
  • Ferraro S, Panteghini M. The role of laboratory in ensuring appropriate test requests. Clin Biochem. 2017;50:555–561.
  • Maillet E, Pare G, Currie LM, et al. Laboratory testing in primary care: a systematic review of health IT impacts. Int J Med Inform. 2018;116:52–69.
  • Singh H, Schiff GD, Graber ML, et al. The global burden of diagnostic errors in primary care. BMJ Qual Saf. 2017;26:484–494.
  • Rudolf JW, Dighe AS. Decision support tools within the electronic health record. Clin Lab Med. 2019;39:197–213.
  • Plebani M, Aita A, Padoan A, et al. Decision support and patient safety. Clin Lab Med. 2019;39:231–244.
  • Delahanty RJ, Alvarez J, Flynn LM, et al. Development and evaluation of a machine learning model for the early identification of patients at risk for sepsis. Ann Emerg Med. 2019;73:334–344.
  • Rhee C, Dantes RB, Epstein L, et al. Using objective clinical data to track progress on preventing and treating sepsis: CDC’s new ‘Adult Sepsis Event’ surveillance strategy. BMJ Qual Saf. 2019;28:305–309.
  • Hall MJ, Forman AD, Pilarski R, et al. Gene panel testing for inherited cancer risk. J Natl Compr Canc Netw. 2014;12:1339–1346.
  • Griener TP, Naugler C, Chan WW, et al. Sociodemographic correlates of urine culture test utilization in Calgary, Alberta. BMC Urol. 2018;18.
  • Rosenbaum MW, Baron JM. Using machine learning-based multianalyte delta checks to detect wrong blood in tube errors. Am J Clin Pathol. 2018;150:555–566.
  • Luo Y, Szolovits P, Dighe AS, et al. Using machine learning to predict laboratory test results. Am J Clin Pathol. 2016;145:778–788.
  • Mohammed EA, Mohamed MM, Far BH, et al. Peripheral blood smear image analysis: a comprehensive review. J Pathol Inform. 2014;5:9.
  • Mainz J. Defining and classifying clinical indicators for quality improvement. Int J Qual Health Care. 2003;15:523–530.
  • ISO. Medical laboratories: particular requirements for quality and competence. ISO 15189:2012. Geneva (Switzerland): International Organization for Standardization; 2012.
  • Plebani M, Astion ML, Barth JH, et al. Harmonization of quality indicators in laboratory medicine. A preliminary consensus. Clin Chem Lab Med. 2014;52:951–958.
  • Plebani M, Sciacovelli L, Aita A. Quality indicators for the total testing process. Clin Lab Med. 2017;37:187–205.
  • Sciacovelli L, Lippi G, Sumarac Z, et al.; Working Group “Laboratory Errors and Patient Safety” of International Federation of Clinical Chemistry (IFCC). Quality indicators in laboratory medicine: the status of the progress of IFCC Working Group “Laboratory Errors and Patient Safety” project. Clin Chem Lab Med. 2017;55:348–357.
  • Sciacovelli L, Panteghini M, Lippi G, et al. Defining a roadmap for harmonizing quality indicators in Laboratory Medicine: a consensus statement on behalf of the IFCC Working Group “Laboratory Error and Patient Safety” and EFLM Task and Finish Group “Performance specifications for the extra-analytical phases. Clin Chem Lab Med. 2017;55:1478–1488.
  • Sciacovelli L, Aita A, Plebani M. Extra-analytical quality indicators and laboratory performances. Clin Biochem. 2017;50:632–637.
  • Plebani M, Sciacovelli L, Aita A, et al. Harmonization of pre-analytical quality indicators. Biochem Med. 2014;24:105–113.
  • Diekema DJ, Saubolle MA. Clinical microbiology and infection prevention. J Clin Microbiol. 2011;49:S57–S60.
  • Lee F. Diagnostics and laboratory role in outbreaks. Curr Opin Infect Dis. 2017;30:419–424.
  • Nikolayevskyy V, Niemann S, Anthony R, et al. Role and value of whole genome sequencing in studying tuberculosis transmission. Clin Microbiol Infect. 2019;25:1377–1382.
  • Anderson DJ, Jenkins TC, Evans SR, et al.; Stewardship, Infection Control Committee of the Antibacterial Resistance Leadership G. 2017. The role of stewardship in addressing antibacterial resistance: stewardship and Infection Control Committee of the Antibacterial Resistance Leadership Group. Clin Infect Dis 64:S36–S40.
  • Avdic E, Carroll KC. The role of the microbiology laboratory in antimicrobial stewardship programs. Infect Dis Clin North Am. 2014;28:215–235.
  • Dik JH, Poelman R, Friedrich AW, et al. Integrated stewardship model comprising antimicrobial, infection prevention, and diagnostic stewardship (AID Stewardship). J Clin Microbiol. 2017;55:3306–3307.
  • Bouza E, Munoz P, Burillo A. Role of the clinical microbiology laboratory in antimicrobial stewardship. Med Clin North Am. 2018;102:883–898.
  • Lowman W. Key to antimicrobial stewardship success: surveillance by diagnostic microbiology laboratories. S Afr Med J. 2015;105:359–360.
  • Morency-Potvin P, Schwartz DN, Weinstein RA. Antimicrobial stewardship: how the microbiology laboratory can right the ship. Clin Microbiol Rev. 2017;30:381–407.
  • Cavalieri SJ, Kwon S, Vivekanandan R, et al. Effect of antimicrobial stewardship with rapid MALDI-TOF identification and Vitek 2 antimicrobial susceptibility testing on hospitalization outcome. Diagn Microbiol Infect Dis. 2019;95:208–211.
  • CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Approved Guideline. 29th ed. CLSI document M100. Wayne (PA): Clinical Laboratory Standards Institute; 2019.
  • Fernandez J, Vazquez F. The Importance of cumulative antibiograms in diagnostic stewardship. Clin Infect Dis. 2019;69:1086–1087.
  • Goff DA, Jankowski C, Tenover FC. Using rapid diagnostic tests to optimize antimicrobial selection in antimicrobial stewardship programs. Pharmacotherapy. 2012;32:677–687.
  • Perez KK, Olsen RJ, Musick WL, et al. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia. J Infect. 2014;69:216–225.
  • Perez KK, Olsen RJ, Musick WL, et al. Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch Pathol Lab Med. 2013;137:1247–1254.
  • Wagar EA. Credibility. Arch Pathol Lab Med. 2014;138:873–875.
  • Tong EN, Sidhu D. Principles of laboratory medicine: evaluating a pilot program for undergraduate laboratory medical education. Can J Pathol. 2016;8:44–51.
  • McDonald JM. Clinical laboratory scientist training–a need for reform. Clin Chem. 1995;41:817–818.
  • Burke MD. Clinical pathology residency training. The need for reform. Arch Pathol Lab Med. 1994;118:489–490.
  • Plebani M. Clinical laboratories: production industry or medical services? Clin Chem Lab Med. 2015;53:995–1004.
  • Strom CM. Changing trends in laboratory testing in the United States: a personal, historical perspective. Clin Lab Med. 2012;32:651–664.
  • Kassirer JP. Imperatives, expediency, and the new diagnosis. Diagnosis. 2014;1:11–12.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.